Ranjan Piyush, Rukadikar Atul R, Hada Vivek, Mohanty Aroop, Singh Parul
Department of Microbiology, All India Institute of Medical Science (AIIMS) Gorakhpur, Uttar Pradesh, India.
Iran J Microbiol. 2024 Aug;16(4):470-476. doi: 10.18502/ijm.v16i4.16305.
This study evaluated the efficacy of the TrueLab™ Real Time mini-PCR system in providing rapid and accurate diagnostic results for tuberculosis (TB) detection in India. The goal is to improve case detection and accelerate treatment in settings with limited resources.
This prospective study was conducted by the Department of Microbiology on 120 patients, age ranging from >=15 years with at least two clinical symptoms of pulmonary TB. Molbio and Universal Cartridge Based Sample Prep were the 2 methods used for processing sputum samples. The diagnosis was based on the MTB Real Time PCR test, which has a detection limit of 100 CFU/mL. Patients under 15 years, samples lacking clinical background, saliva specimens or extra-pulmonary TB cases were excluded from the study.
A total of 44.17% samples were positive for TB with maximum positivity in the age group 31-45 years. Positivity rate was found to be higher in females. In 4.17% of cases there was rifampicin resistance, which was significantly high in previously treated cases. Comparison of Truenat with Ziehl-Neelsen and fluorescent method revealed that it was more sensitive and less time consuming.
Truenat MTB/RIF is a sensitive detection system for TB with rapid results, which serves as an important tool in the early management of tuberculosis patients and drug-resistant-TB cases.
本研究评估了TrueLab™实时微型聚合酶链反应(PCR)系统在印度用于结核病(TB)检测时提供快速准确诊断结果的效能。目标是在资源有限的环境中改善病例发现并加速治疗。
本前瞻性研究由微生物学系对120例年龄≥15岁且至少有两种肺结核临床症状的患者进行。Molbio和基于通用试剂盒的样本制备是用于处理痰液样本的两种方法。诊断基于MTB实时PCR检测,其检测限为100 CFU/mL。15岁以下患者、缺乏临床背景的样本、唾液标本或肺外结核病例被排除在研究之外。
共有44.17%的样本结核检测呈阳性,31 - 45岁年龄组的阳性率最高。女性的阳性率更高。在4.17%的病例中存在利福平耐药,在既往治疗过的病例中显著偏高。将Truenat与萋尼氏染色法和荧光法进行比较发现,Truenat更灵敏且耗时更短。
Truenat MTB/RIF是一种用于结核病的灵敏检测系统,结果快速,是结核病患者和耐多药结核病病例早期管理的重要工具。